Martin Nicklasson
business
Orexo
Sweden
Biography
Chairman of the Board of Directors since 2012 M.Sc. Pharm. PhD and Associate Professor at the Faculty of Pharmacy, Uppsala University. Other appointments: Chairman of the Board of Zealand Pharma A/S and Kymab Group Ltd. Board member of Basilea Pharmaceutica Ltd., and Biocrine AB. Member of the Royal Academy of Engineering Sciences (IVA). Previous appointments: CEO at Swedish Orphan Biovitrum AB 2007–2010. Astra/AstraZeneca 1978–1989 and 1991–2007, e.g. responsible for global drug development and marketing and business development within AstraZeneca Ltd., and CEO of AstraZeneca Sweden AB, CEO of Astra Hässle AB and responsible for R&D within KABI. Holds 10,000 shares and stock options entitled to 162,916 shares, as of December 31 2016.
Research Interest
Interested in business
